Earnings call transcript: Integra LifeSciences tops Q3 EPS view, shares rise 2.7%

Integra LifeSciences reported Q3 2026 earnings that exceeded analyst expectations, with adjusted EPS at $0.59, surpassing the $0.5608 consensus estimate. Revenue increased 2.3% to $411.2 million, slightly below the $414.25 million forecast, due to a flooding disruption at the Cincinnati plant. The company lowered its full-year guidance for revenue and earnings, and while adjusted gross margin declined, operating cash flow reached a record $96 million. Shares rose 2.7% following the earnings release.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.